Resonetics Acquires Resolution Medical

Resonetics Acquires Agile MV

June 13, 2022

Medical Devices

Resonetics has acquired Agile MV, a Montreal-based product development and turnkey device assembly company focused on electrophysiology and cardiology catheters. The acquisition expands Resonetics' product development and finished device assembly capabilities and will rebrand the combined Design & Development Services business as AGILE Product Development with locations in Boston, San Diego, and Montreal.

Carlyle Acquires Minority Stake in Resonetics

December 3, 2021

Medical Devices

Funds managed by Carlyle have acquired a significant minority equity stake in Resonetics, valuing the specialized medical device contract manufacturer at approximately $2.25 billion. Carlyle will join existing investor GTCR as a meaningful shareholder while Sverica retains a minority position; the investment will support Resonetics’ continued organic growth, international expansion and add-on acquisition strategy.

Resonetics Acquires Eden Holdings to Add Injection Molding and Precision Tooling

September 29, 2025

Medical Devices

Resonetics has acquired Eden Holdings (comprising Eden Manufacturing and Eden Tool), adding precision micro-molding, insert-molding, and advanced machining and tooling to its MedTech manufacturing capabilities. The deal expands Resonetics' polymer and tooling capabilities to better serve medical device OEM end markets including robotic surgery, minimally invasive surgery, electrophysiology, and rapid diagnostics.

Resonetics Acquires Memry Corporation and SAES Smart Materials

January 9, 2023

Medical Devices

Resonetics (backed by Carlyle and GTCR) agreed to acquire Memry Corporation and the SAES Medical Nitinol business (SAES Smart Materials) from SAES Getters S.p.A., a deal valued at $900 million and completed in 2023. The transaction expands Resonetics' nitinol material and component manufacturing capabilities across facilities in Bethel, Connecticut; New Hartford, New York; and Menlo Park, California, adding roughly 550–600 employees and enhanced EDM, laser processing, tubing, wire and melt-to-component capabilities for medical device customers.

Arcline Investment Management Acquires Controlling Stake in Resolution Medical

June 2, 2021

Medical Devices

Arcline Investment Management acquired a controlling stake in Resolution Medical from founders Steve Schmidt and Shawn Patterson, with Culper Capital Partners joining as a minority investor. Resolution Medical, a Minneapolis-based medical device CDMO specializing in complex interventional therapies, will retain its senior leadership while Luke Johnson joins as Executive Chairman as Arcline seeks to build a leading CDMO platform.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition is expected to expand Boston Scientific’s electrophysiology and structural heart portfolios by adding the RF NRG and VersaCross transseptal platforms and related guidewires, sheaths, and dilators.